The invention encompasses the novel class of compounds represented by formula I, which are caspase-3 inhibitors. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of caspase-3 mediated diseases comprising compounds of formula I.

L'invenzione comprende il codice categoria del romanzo dei residui rappresentati dalla formula I, che sono inibitori caspase-3. ## del ## STR1 L'invenzione inoltre comprende determinate composizioni farmaceutiche per il trattamento delle malattie mediate caspase-3 che contengono i residui la formula I.

 
Web www.patentalert.com

< 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents

< Sodium channel modulators

> ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO [1,2-G]CHROM-3-ENE, BENZO[1,2-G]-THIOCHROM-3-ENE AND BENZO [1,2-G]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY

> Secreted protein HT5GJ57

~ 00067